LUNAC THERAPEUTICS LIMITED

1. Company facts

Status

liquidation

Lifecycle

⚰️ Wound down — Dissolved, in liquidation, or being struck off.

Jurisdiction

england-wales

Registered office

29 Craven Street, London, WC2N 5NT

SIC codes

72190 — Other research and experimental development on natural sciences and engineering

Accounts next due

2026-02-28

Confirmation statement next due

2026-05-01

2. Directors (4 active)

CANNING, Mary Eugenie, Dr

director · appointed 2019-09-20 · born 6/1974 (age 52)

FINAN, Peter Michael, Dr

director · appointed 2019-09-20 · born 7/1967 (age 59)

PHILIPPOU, Helen, Professor

director · appointed 2018-04-18 · born 3/1968 (age 58)

TURNER, Mervyn

director · appointed 2019-10-04 · born 8/1946 (age 80)

3. Shareholders (1 active)

Epidarex Capital Iii Uk,Lp

25-50% shares · 25-50% voting

4. Group structure

Epidarex Capital Iii Uk,Lp holds 25-50% — a significant corporate investor but not a controlling parent.

Epidarex Capital Iii Uk,Lp

Corporate parent · 25-50%

5. Security

1 total charge (1 outstanding, 0 satisfied).

Headline verdict

Opportunity score

36/100 (Watch)

Owner dependency

moderate — 55/100

Red flags

4 high · 0 medium · 0 low